Mounjaro wasn’t designed with sexual health in mind – it’s approved for type 2 diabetes, and libido was never a measured outcome in its trials. But plenty of patients notice a change, in both directions, and there’s now real research explaining why. Here’s what the evidence actually shows, separate from anecdote.
Key takeaways
- Tirzepatide (Mounjaro’s active ingredient) was never studied for sexual function directly – no clinical trial has measured libido as an outcome, so most of what’s known comes from smaller studies and real-world reports.
- The clearest evidence points toward improvement, not decline, for men with obesity-related low testosterone. A 2025 study found tirzepatide raised testosterone and improved erectile function more than testosterone therapy itself in this specific group.
- A documented case report showed the opposite in one woman – decreased desire and difficulty with arousal that resolved when she stopped tirzepatide and returned when she restarted it, suggesting a real, if individual, drug effect is possible.
- Weight loss itself is the biggest driver of improvement for most patients – better blood flow, more energy, improved self-image, and normalized hormone levels associated with meaningful weight loss.
- Early treatment can temporarily suppress libido through fatigue, nausea, and the body’s response to eating less, separate from any longer-term hormonal effect.
- Responses are genuinely individual – increased desire, decreased desire, and no change are all reported, and none of them is the “expected” outcome.
What the research actually shows
Men with obesity-related low testosterone: the strongest evidence for improvement
The most direct evidence comes from a 2025 study in Reproductive Biology and Endocrinology that compared tirzepatide against lifestyle changes alone and against testosterone replacement therapy in 83 men with obesity and metabolic hypogonadism. After two months, the tirzepatide group had significantly higher testosterone, along with better erectile function scores, than either comparison group – including men on testosterone therapy itself.
This matters for a specific reason: obesity itself suppresses testosterone production, so treating the underlying weight issue can correct the hormonal problem more effectively than replacing testosterone directly, without the risks that come with TRT. Our guide on understanding testosterone replacement therapy covers that separate path, worth discussing with your provider if hormone levels remain a concern alongside weight management.
Broader weight-loss-and-erectile-function data
A separate study tracking 312 men with obesity and erectile dysfunction through significant weight loss (averaging 18%) found that 31% no longer met the clinical threshold for ED, and 45% reported a meaningful improvement in erectile function scores. This wasn’t specific to tirzepatide, but it’s consistent with what the tirzepatide-specific study found, and it points to weight loss as the likely mechanism rather than a direct drug effect on sexual function.
A documented case of decreased libido
Not every report points toward improvement. A published case report described a 36-year-old woman who developed decreased sexual desire, genital dryness, and difficulty reaching orgasm while on tirzepatide. Her symptoms improved after stopping the medication and returned when she restarted it – a pattern that suggests a direct link in her case, even though it’s a single documented report rather than a trial finding.
What’s missing from the research
No randomized controlled trial has studied GLP-1 or dual-agonist drugs specifically for their effect on libido. Everything above comes from secondary outcomes in metabolic studies, case reports, or trials designed to measure something else. That’s an important gap – it means the honest answer to “does Mounjaro affect libido” is “it can, in either direction, but we don’t have the kind of dedicated research that would explain exactly why or how often”
Why libido changes at all on a drug that doesn’t target it
Tirzepatide doesn’t act directly on sex hormones or sexual function. The changes patients report seem to run through a few indirect paths:
- Metabolic improvement. Better insulin sensitivity and meaningful weight loss are linked to improved testosterone in men and more balanced hormone signaling in women – both relevant to libido.
- Physical changes. Improved blood flow, reduced inflammation, and better stamina as weight decreases can support sexual function in ways unrelated to hormones directly.
- Psychological factors. Improved body image and confidence after weight loss are commonly cited by patients as reasons desire increased – a pattern also discussed in our guide on low testosterone and erectile dysfunction.
- Early-treatment fatigue. Nausea, reduced calorie intake, and the body’s adjustment to a new dose can temporarily suppress libido in the first weeks, separate from any longer-term effect.
If you’re noticing a change
Track when it started relative to your dose or a recent increase, alongside your energy levels, sleep, and mood – early-treatment side effects and true hormonal shifts often look different once you separate out the timing. A change that shows up right after a dose increase and fades within a couple of weeks is more likely tied to short-term side effects than a lasting hormonal shift.
If the change is persistent or distressing, that’s worth bringing to your provider directly rather than assuming it will resolve on its own – particularly for women, since the documented case above showed genuine, reversible drug-related symptoms in at least one instance.
Conclusion
The strongest research on Mounjaro and libido points toward improvement, particularly for men with obesity-related low testosterone, where tirzepatide outperformed testosterone therapy itself in one direct comparison. But that’s not the whole picture – a documented case shows the opposite is possible too, and no trial has studied this question directly enough to say how common either outcome is. If you notice a change, tracking its timing and talking to your provider is more useful than assuming it’s either permanent or purely psychological.
If sexual side effects or changes are affecting your treatment, book a free consultation with Heally – a licensed provider can help sort out what’s happening and adjust your plan if needed.
FAQ
Does Mounjaro increase or decrease libido?
Both are reported. The strongest research shows improvement, especially in men with obesity-related low testosterone, but a documented case report shows decreased libido in at least one patient that resolved off the drug and returned on it. Individual response varies significantly.
Can Mounjaro raise testosterone?
In men with obesity-related metabolic hypogonadism, a 2025 study found tirzepatide raised testosterone more effectively than testosterone replacement therapy itself over two months, likely by treating the underlying weight-related cause rather than adding hormones directly.
Is low libido a known side effect of Mounjaro?
It isn’t listed as a common side effect in clinical trials, since sexual function wasn’t a measured outcome. Reports come from real-world use and a small number of published case reports, not trial-level data.
Will my libido improve as I lose weight on Mounjaro?
For many patients, yes – weight loss is linked to improved blood flow, better hormone balance, and improved body image, all of which support sexual function. This isn’t universal, and some patients notice no change at all.
Why might libido drop in the first few weeks on Mounjaro?
Early nausea, fatigue, and reduced calorie intake can temporarily suppress desire as your body adjusts, separate from any longer-term hormonal effect. This tends to improve as your body adapts to a stable dose.
Should I stop Mounjaro if I notice a change in libido?
Not without talking to your provider first. A persistent or distressing change is worth discussing, since it may be manageable with a dose adjustment rather than requiring you to stop treatment.
Does this apply the same way to Zepbound, since it’s the same drug?
Since Zepbound and Mounjaro are both tirzepatide, the underlying mechanisms and research findings are the same – the difference is the FDA-approved indication (diabetes for Mounjaro, weight management for Zepbound), not the drug’s effect on the body.
Is there research specifically on tirzepatide and libido, not just weight loss in general?
Some, but limited. The 2025 hypogonadism study is the most direct tirzepatide-specific data available, alongside individual case reports. No large randomized trial has studied tirzepatide’s effect on libido as a primary outcome.
Related reading on Heally:
- How to manage diarrhea on tirzepatide
- Mounjaro vs Zepbound: what’s actually different
- What is the tirzepatide starting dose for weight loss?
Sources
- Reproductive Biology and Endocrinology – La Vignera S, et al., tirzepatide vs. lifestyle vs. testosterone therapy in obesity-related hypogonadism (2025)
- The GLP Spot – GLP-1s and sexual health: libido, testosterone, and what the research shows
- FDA – Mounjaro prescribing information
- FDA – MedWatch adverse event reporting
Medical disclaimer: This article is for informational purposes and reflects publicly available research as of September 2026. It does not replace medical advice. Always consult a licensed healthcare provider about persistent or distressing side effects, or before starting, stopping, or changing any prescription medication.
